161 related articles for article (PubMed ID: 17353162)
1. APRIL is increased in serum of patients with brain glioblastoma multiforme.
Iłzecka J; Iłzecki M
Eur Cytokine Netw; 2006 Dec; 17(4):276-80. PubMed ID: 17353162
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid.
Watanabe R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Kuwano Y; Tada Y; Maruyama N; Okochi H; Tamaki K
J Dermatol Sci; 2007 Apr; 46(1):53-60. PubMed ID: 17250993
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
[TBL] [Abstract][Full Text] [Related]
6. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS
Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703
[TBL] [Abstract][Full Text] [Related]
7. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
[TBL] [Abstract][Full Text] [Related]
8. B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease.
Fabris M; De Vita S; Visentini D; Fabro C; Picierno A; Lerussi A; Villalta D; Alessio MG; Tampoia M; Tonutti E
Ann N Y Acad Sci; 2009 Sep; 1173():268-73. PubMed ID: 19758161
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
[TBL] [Abstract][Full Text] [Related]
11. A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis.
Thangarajh M; Masterman T; Hillert J; Moerk S; Jonsson R
Scand J Immunol; 2007 Jan; 65(1):92-8. PubMed ID: 17212772
[TBL] [Abstract][Full Text] [Related]
12. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
13. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
14. Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients.
Carlsson A; Persson O; Ingvarsson J; Widegren B; Salford L; Borrebaeck CA; Wingren C
Proteomics Clin Appl; 2010 Jul; 4(6-7):591-602. PubMed ID: 21137077
[TBL] [Abstract][Full Text] [Related]
15. Effects of cholecystectomy (laparoscopic versus open) on PMN-elastase.
Schietroma M; Carlei F; Cappelli S; Pescosolido A; Lygidakis NJ; Amicucci G
Hepatogastroenterology; 2007 Mar; 54(74):342-5. PubMed ID: 17523270
[TBL] [Abstract][Full Text] [Related]
16. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
17. Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2008 May; 117(5):343-6. PubMed ID: 17995989
[TBL] [Abstract][Full Text] [Related]
18. Immunotreatment in patients with glioblastoma multiforme--a histopathological evaluation of reactive and inflammatory changes.
Persson A; Skagerberg G; Salford LG; Englund E;
Clin Neuropathol; 2005; 24(5):201-8. PubMed ID: 16167543
[TBL] [Abstract][Full Text] [Related]
19. Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL.
Nagatani K; Itoh K; Nakajima K; Kuroki H; Katsuragawa Y; Mochizuki M; Aotsuka S; Mimori A
Arthritis Rheum; 2007 Nov; 56(11):3554-63. PubMed ID: 17968879
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
